KR182283B1 - Contraceptic composition containing minimum 25 oral daily dosage forms - Google Patents

Contraceptic composition containing minimum 25 oral daily dosage forms

Info

Publication number
KR182283B1
KR182283B1 KR900071321A KR900071321A KR182283B1 KR 182283 B1 KR182283 B1 KR 182283B1 KR 900071321 A KR900071321 A KR 900071321A KR 900071321 A KR900071321 A KR 900071321A KR 182283 B1 KR182283 B1 KR 182283B1
Authority
KR
Grant status
Grant
Patent type
Prior art keywords
contraceptic
dosage forms
composition containing
daily dosage
oral daily
Prior art date
Application number
KR900071321A
Inventor
Samuel A Pasquale
Original Assignee
Samuel A Pasquale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date
Family has litigation

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
KR900071321A 1988-10-20 1990-06-20 Contraceptic composition containing minimum 25 oral daily dosage forms KR182283B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US07260447 US4921843A (en) 1988-10-20 1988-10-20 Contraception system and method
PCT/US1989/004697 WO1990004330A1 (en) 1988-10-20 1989-10-19 Contraception system and method

Publications (1)

Publication Number Publication Date
KR182283B1 true KR182283B1 (en) 1999-05-01

Family

ID=22989203

Family Applications (1)

Application Number Title Priority Date Filing Date
KR900071321A KR182283B1 (en) 1988-10-20 1990-06-20 Contraceptic composition containing minimum 25 oral daily dosage forms

Country Status (8)

Country Link
US (1) US4921843A (en)
EP (1) EP0397823B1 (en)
JP (1) JP3001216B2 (en)
KR (1) KR182283B1 (en)
CA (1) CA2001144C (en)
DE (2) DE68928897T2 (en)
FI (1) FI103951B1 (en)
WO (1) WO1990004330A1 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
DE4104385C1 (en) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
DE4344405C2 (en) * 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulation-inhibiting agent for hormonal contraception and methods
DE4411585A1 (en) * 1994-03-30 1995-10-05 Schering Ag The pharmaceutical combination product for hormonal contraception
DE4429374C1 (en) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmaceutical preparations for contraception / hormone replacement with biogenic estrogen
DE19513662A1 (en) * 1995-04-08 1996-10-10 Schering Ag The pharmaceutical combination product for hormonal contraception
DE19540253C2 (en) * 1995-10-28 1998-06-04 Jenapharm Gmbh Multiphase product for contraception based on natural estrogens
US20050032756A1 (en) * 1995-10-28 2005-02-10 Michael Dittgen Multistage preparation for contraception based on natural estrogens
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive
US6479475B1 (en) 1996-07-26 2002-11-12 Wyeth Oral contraceptive
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
US6451778B1 (en) 1996-07-26 2002-09-17 Wyeth Oral contraceptive
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
FR2754179B1 (en) 1996-10-08 1998-12-24 Theramex New composition and its use hormononale
US6251956B1 (en) 1998-08-20 2001-06-26 Ortho Pharmaceutical Corporation Combination progestin oral contraceptive regimen
US6214815B1 (en) 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
EP1163901B1 (en) * 1999-02-26 2008-09-10 SHIONOGI & CO., LTD. Chewable soft capsules having improved administration properties and process for producing the same
WO2001030355A1 (en) 1999-10-25 2001-05-03 Laboratoire Theramex Contraceptive medicine based on a progestational agent and an oestrogen and preparation method
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US7989436B2 (en) * 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
JP2004140323A (en) * 2002-08-20 2004-05-13 Sharp Corp Semiconductor laser and its manufacturing method
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
EP1622623A4 (en) * 2003-04-11 2009-03-18 Barr Lab Inc Methods of administering estrogens and progestins
EP1689411B1 (en) * 2003-11-14 2008-10-08 Warner Chilcott Company Inc. Graduated estrogen contraceptive
EP1550447A1 (en) * 2004-01-02 2005-07-06 Schering Aktiengesellschaft Menstrual cycle control and improvement of conception rates in females
CN1933873A (en) * 2004-03-19 2007-03-21 沃纳奇尔科特公司 Extended cycle multiphasic oral contraceptive method
DE102004019743B4 (en) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Multiphase product for contraception based on a natural estrogen
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
US7704984B2 (en) * 2005-04-22 2010-04-27 Warner Chilcott Company, Llc Extended estrogen dosing contraceptive regimen
US8153616B2 (en) * 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (en) * 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Application of estradiol valerate or 17ß-estradiol in combination with dienogest for oral therapy to maintain and/or increase the female libido

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6615481A (en) * 1966-11-02 1968-05-03
US3409721A (en) * 1967-09-15 1968-11-05 Neomed Lab Inc Oral dosage system effective to control the reproduction cycle
US4372951A (en) * 1979-10-11 1983-02-08 Nichols Vorys Vaginal delivery for physiologic follicular-luteal steroid treatment
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4616006A (en) * 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4544554A (en) * 1983-09-26 1985-10-01 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DE3347125A1 (en) * 1983-12-22 1985-07-11 Schering Ag Mehrstufenkombinationspraeparat and its use for oral contraception

Also Published As

Publication number Publication date Type
EP0397823B1 (en) 1999-01-07 grant
EP0397823A4 (en) 1991-04-03 application
JP3001216B2 (en) 2000-01-24 grant
CA2001144C (en) 1999-07-20 grant
EP0397823A1 (en) 1990-11-22 application
US4921843A (en) 1990-05-01 grant
DE68928897D1 (en) 1999-02-18 grant
FI903106A0 (en) 1990-06-20 application
WO1990004330A1 (en) 1990-05-03 application
JPH03502932A (en) 1991-07-04 application
FI103951B (en) 1999-10-29 application
CA2001144A1 (en) 1990-04-20 application
DE68928897T2 (en) 1999-07-29 grant
FI103951B1 (en) 1999-10-29 grant
FI903106D0 (en) grant

Similar Documents

Publication Publication Date Title
JPS62185018A (en) Medicinal composition
JPS6289614A (en) Oral sanitary composition
JPS63101321A (en) Ibuprofen-containing medicinal composition
JPS6333321A (en) Oral composition
JPS62283930A (en) Medicinal composition
JPS63303928A (en) Medicinal composition
JPS60233008A (en) Oral sanitary composition
JPS63258404A (en) Oral composition
JPS6341420A (en) Analgesic medicinal composition
GB2222770B (en) Pharmaceutical compositions containing cyclosporins
JPS6296409A (en) Plaque preventive oral composition
JPS62164614A (en) Oral sanitary composition
JPS60193910A (en) Dental sanitary composition
CN1037652A (en) Antibacterial composition for oral administration
JPS62286917A (en) Plaque preventing oral composition
JPS63264528A (en) Medicinal composition
JPS62126116A (en) Oral sanitary composition
JPS63146815A (en) Ibuprofen-containing medicinal composition
JPS6345215A (en) Oral sanitary composition
JPS62289525A (en) Calcium modulative compound and pharmaceutical composition
JPS62265228A (en) Medicinal composition containing specific gem-diphosphonates